Sector dividends Neurogene Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 20:20:11 23/01/2026 GMT			5-day change	1st Jan Change
18.36 ^USD	-3.34%		+4.87%	-10.66%

01-12	Neurogene Announces Recent Achievements and Anticipated 2026 Key Milestones for NGN-401, a Potential Best-In-Class Gene Therapy for Rett Syndrome	CI
11-13	Gene therapy developer Neurogene's Q3 net loss widens	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Dividend Yield (Y)	Dividend Yield (Y+1)	P/E (Y)	Price to Book (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Capi.($)
NEUROGENE INC.	-	-	-4.44x	-	-	-	-0.57x	294M
LONZA GROUP AG	0.88%	1.01%	38.6x	3.98x	5.61x	18.76x	27.54x	49.33B
IQVIA HOLDINGS INC.	-.--%	-.--%	33.64x	6.41x	3.34x	14.3x	23.18x	40.71B
BEONE MEDICINES AG	-.--%	-.--%	103.66x	9.38x	6.64x	66.74x	96.92x	37.49B
CELLTRION, INC.	0.35%	0.36%	54.92x	2.63x	11.26x	31.31x	40.42x	31.07B
REVOLUTION MEDICINES, INC.	-.--%	-.--%	-21.27x	14.47x	6171.3x	-20.16x	-19.92x	22.97B
MEDPACE HOLDINGS, INC.	-.--%	-.--%	40.96x	40.89x	6.64x	30.18x	31.63x	17.08B
EUROFINS SCIENTIFIC SE	0.89%	0.95%	27.41x	2.44x	2.21x	9.91x	15.33x	14.81B
ICON PUBLIC LIMITED COMPANY	-.--%	-.--%	27.86x	1.53x	2.14x	10.94x	12.17x	14.26B
ASCENDIS PHARMA A/S	-.--%	-.--%	-56.02x	1496.95x	16.33x	-120.33x	-90.54x	14.03B
IONIS PHARMACEUTICALS, INC.	-.--%	-.--%	-36.09x	48.11x	13.72x	-39.11x	-34.29x	13.25B
TEMPUS AI, INC.	-.--%	-.--%	-46x	23.78x	10.09x	25673.78x	-208.89x	12.16B
QIAGEN N.V.	0.37%	0.42%	27.66x	3x	5.51x	14.92x	18.6x	11.18B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-.--%	-.--%	53.45x	3.13x	3.23x	13.41x	16.32x	11.03B
BIO-TECHNE CORPORATION	0.46%	0.46%	54.41x	4.99x	8.83x	25.02x	27.23x	10.85B
Average	0.21%	0.23%	19.92x	118.69x	447.63x	1,837.83x	-2.99x	20.03B
Weighted average by Cap.	0.26%	0.28%	31.76x	80.06x	478.52x	1,052.41x	13.62x